0001012975-19-000673.txt : 20191112
0001012975-19-000673.hdr.sgml : 20191112
20191112155059
ACCESSION NUMBER: 0001012975-19-000673
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190930
FILED AS OF DATE: 20191112
DATE AS OF CHANGE: 20191112
EFFECTIVENESS DATE: 20191112
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCH VENTURE CORP
CENTRAL INDEX KEY: 0001274403
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19358
FILM NUMBER: 191209071
BUSINESS ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 7733806600
MAIL ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001274403
XXXXXXXX
09-30-2019
09-30-2019
ARCH VENTURE CORP
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS RD. #1025
CHICAGO
IL
60631
13F HOLDINGS REPORT
028-19358
N
Mark McDonnell
Managing Director, CFO and CAO
773-380-6600
/s/ Mark McDonnell
Chicago
IL
11-12-2019
0
5
91368
false
INFORMATION TABLE
2
ARCH.xml
CHIASMA INC
COM
16706W102
5924
1196776
SH
SOLE
0
0
1196776
FATE THERAPEUTICS INC
COM
31189P102
11126
716392
SH
SOLE
0
0
716392
KURA ONCOLOGY INC
COM
50127T109
13749
906307
SH
SOLE
0
0
906307
RUBIUS THERAPEUTICS INC
COM
78116T103
20554
2618351
SH
SOLE
0
0
2618351
SYROS PHARMACEUTICALS INC
COM
87184Q107
40015
3855051
SH
SOLE
0
0
3855051